A Nurse Cohort Study in Xiamen, China

Sponsor
The First Affiliated Hospital of Xiamen University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03799653
Collaborator
(none)
10,000
1
117.4
85.2

Study Details

Study Description

Brief Summary

The Nurse Cohort Study Xiamen (NCSX) is an open-ended prospective cohort study with very broad research aims. The primary objectives of the NCSX is planned to examine genetic, epigenetic, biological, psychological, social, lifestyle and other environmental factors of nurses in relation to incidence and progression of the common chronic diseases, such as hypertension, ischemic heart disease, stroke, diabetes, chronic kidney disease and some cancers, which are emerging with economic development in Xiamen, China. Specifically, we intend to test whether empirically driven hypothesis and emerging risk factors mainly developed in response to observations in economically developed Western societies apply in a population living in a rapid changing lifestyle in China now.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Detailed Description

Objectives: To establish a cohort of about 10,000 registered nurses (aged 20 or over) in Xiamen, China; to describe the baseline major risk factors; to analyze their interrelationships; and to examine the risks of incidence and progression of major chronic diseases, such as hypertension, stroke, CKD and cancers, and all-cause and cause-specific mortality by different levels of the risk factors after about 5 years follow-up.

Design: A prospective cohort study. Setting: 7 public hospitals in Xiamen, China. Participants: About 10,000 registered nurses (aged 20 or over) who work in public hospitals in Xiamen, China.

Main outcome: Incidences of common chronic diseases, such as CVD, diabetes, chronic kidney disease, and cancers; progression of these diseases; all cause and specific-cause mortality.

Hypothesis: Relative risks of major risk factors. Results of the study should have strong impact on prevention and control of these diseases and promoting nurses'health in the local population.

Study Design

Study Type:
Observational
Anticipated Enrollment :
10000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective Cohort Study of Common Chronic Diseases on Nurses in Xiamen, China: Nurse Cohort Study Xiamen (NCSX)
Actual Study Start Date :
Mar 20, 2019
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2028

Arms and Interventions

Arm Intervention/Treatment
Nurses

All subjects are registered nurses in Xiamen, China

Other: No intervention
This is a prospective observational study, and there is no intervention.

Outcome Measures

Primary Outcome Measures

  1. Incidence rate [2019.1.21-2024.12.31]

    The incidence rates of common chronic diseases, such as hypertension, The stroke, CKD and cancers

Secondary Outcome Measures

  1. Mortality [2019.1.21-2024.12.31]

    All-cause and cause-specific mortality

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Registered nurses of public hospitals in Xiamen, China;

  • aged 20 years or over;

  • Working in the public hospitals for at least 1 year;

  • Signed the informed consent and agreed to participate in the study;

  • Assuming not moved out of Xiamen for at least 5 years;

Exclusion Criteria:
  • who are unambulatory;

  • who are receiving treatment modalities, which , if omitted, may result in immediate life threatening risk such as chemotherapy or radiotherapy for cancer, or dialysis for renal failure.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The First Affiliated Hospital of Xiamen University Xiamen Fujian China 361003

Sponsors and Collaborators

  • The First Affiliated Hospital of Xiamen University

Investigators

  • Study Chair: Weihua Li, Ph.D., The First Affiliated Hospital of Xiamen University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zhibin LI, Director, The First Affiliated Hospital of Xiamen University
ClinicalTrials.gov Identifier:
NCT03799653
Other Study ID Numbers:
  • KYH2019-002
First Posted:
Jan 10, 2019
Last Update Posted:
Apr 13, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 13, 2022